PainReform Expands into Home Energy Management Sector, Leveraging DeepSolar’s AI-Driven Platform to Address the Growing Solar Optimization Market
PainReform (Nasdaq: PRFX) announced its expansion into the Smart Energy Management sector through the acquisition of DeepSolar, an AI-driven solar optimization software provider. The strategic move marks a significant shift from the company's pharmaceutical focus to tech-enabled markets.
DeepSolar's flagship product, MyDeepSolar, is an application that uses machine learning and predictive analytics to optimize solar energy systems for residential users. The platform offers real-time monitoring, yield forecasting, and performance optimization features to help homeowners maximize their solar investments.
According to Ehud Geller, Chairman and interim CEO, this expansion aligns with global energy trends and leverages a commercially scalable technology platform. The move comes amid increased M&A activity in the solar sector and growing government support through tax credits and smart grid infrastructure initiatives.
PainReform (Nasdaq: PRFX) ha annunciato la sua espansione nel settore della Gestione Energetica Intelligente attraverso l'acquisizione di DeepSolar, un fornitore di software per l'ottimizzazione solare basato su intelligenza artificiale. Questa mossa strategica segna un cambiamento significativo dal focus farmaceutico dell'azienda verso mercati abilitati dalla tecnologia.
Il prodotto di punta di DeepSolar, MyDeepSolar, è un'applicazione che utilizza l'apprendimento automatico e l'analisi predittiva per ottimizzare i sistemi di energia solare per gli utenti residenziali. La piattaforma offre monitoraggio in tempo reale, previsioni di rendimento e funzionalità di ottimizzazione delle prestazioni per aiutare i proprietari di casa a massimizzare i loro investimenti solari.
Secondo Ehud Geller, Presidente e CEO ad interim, questa espansione è in linea con le tendenze energetiche globali e sfrutta una piattaforma tecnologica commercialmente scalabile. Questa mossa arriva in un contesto di crescente attività di fusioni e acquisizioni nel settore solare e di crescente supporto governativo attraverso crediti d'imposta e iniziative per le infrastrutture delle reti intelligenti.
PainReform (Nasdaq: PRFX) anunció su expansión en el sector de Gestión Energética Inteligente a través de la adquisición de DeepSolar, un proveedor de software de optimización solar impulsado por inteligencia artificial. Este movimiento estratégico marca un cambio significativo del enfoque farmacéutico de la empresa hacia mercados habilitados por tecnología.
El producto insignia de DeepSolar, MyDeepSolar, es una aplicación que utiliza aprendizaje automático y análisis predictivo para optimizar sistemas de energía solar para usuarios residenciales. La plataforma ofrece monitoreo en tiempo real, pronósticos de rendimiento y características de optimización de desempeño para ayudar a los propietarios a maximizar sus inversiones solares.
Según Ehud Geller, Presidente y CEO interino, esta expansión se alinea con las tendencias energéticas globales y aprovecha una plataforma tecnológica escalable comercialmente. Este movimiento llega en medio de un aumento de la actividad de fusiones y adquisiciones en el sector solar y un creciente apoyo gubernamental a través de créditos fiscales e iniciativas de infraestructura de redes inteligentes.
PainReform (Nasdaq: PRFX)는 인공지능 기반의 태양광 최적화 소프트웨어 제공업체인 DeepSolar를 인수하여 스마트 에너지 관리 분야로 확장한다고 발표했습니다. 이 전략적 움직임은 회사의 제약 중심에서 기술 기반 시장으로의 중요한 전환을 의미합니다.
DeepSolar의 주력 제품인 MyDeepSolar는 기계 학습과 예측 분석을 사용하여 주거용 사용자들을 위한 태양광 에너지 시스템을 최적화하는 애플리케이션입니다. 이 플랫폼은 실시간 모니터링, 수익 예측 및 성능 최적화 기능을 제공하여 주택 소유자들이 태양광 투자 수익을 극대화할 수 있도록 돕습니다.
Ehud Geller 의장 겸 임시 CEO에 따르면, 이번 확장은 글로벌 에너지 트렌드와 일치하며 상업적으로 확장 가능한 기술 플랫폼을 활용합니다. 이 움직임은 태양광 분야에서의 인수합병 활동 증가와 세금 공제 및 스마트 그리드 인프라 이니셔티브를 통한 정부 지원 증가 속에서 이루어졌습니다.
PainReform (Nasdaq: PRFX) a annoncé son expansion dans le secteur de la gestion énergétique intelligente par l'acquisition de DeepSolar, un fournisseur de logiciels d'optimisation solaire alimentés par l'intelligence artificielle. Ce mouvement stratégique marque un changement significatif de l'orientation pharmaceutique de l'entreprise vers des marchés axés sur la technologie.
Le produit phare de DeepSolar, MyDeepSolar, est une application qui utilise l'apprentissage automatique et l'analyse prédictive pour optimiser les systèmes d'énergie solaire pour les utilisateurs résidentiels. La plateforme offre des fonctionnalités de surveillance en temps réel, de prévision de rendement et d'optimisation des performances pour aider les propriétaires à maximiser leurs investissements solaires.
Selon Ehud Geller, président et PDG par intérim, cette expansion s'aligne sur les tendances énergétiques mondiales et tire parti d'une plateforme technologique commercialement évolutive. Ce mouvement intervient dans un contexte d'activité croissante de fusions et acquisitions dans le secteur solaire et de soutien gouvernemental accru par le biais de crédits d'impôt et d'initiatives d'infrastructure de réseaux intelligents.
PainReform (Nasdaq: PRFX) hat seine Expansion in den Bereich des intelligenten Energiemanagements durch die Übernahme von DeepSolar, einem Anbieter von KI-gesteuerten Softwarelösungen zur Solaroptimierung, bekannt gegeben. Dieser strategische Schritt markiert einen signifikanten Wechsel vom pharmazeutischen Fokus des Unternehmens hin zu technologiegestützten Märkten.
Das Flaggschiffprodukt von DeepSolar, MyDeepSolar, ist eine Anwendung, die maschinelles Lernen und prädiktive Analytik nutzt, um Solarsysteme für private Nutzer zu optimieren. Die Plattform bietet Echtzeitüberwachung, Ertragsprognosen und Leistungsoptimierungsfunktionen, um Hausbesitzern zu helfen, ihre Solarinvestitionen zu maximieren.
Laut Ehud Geller, dem Vorsitzenden und interimistischen CEO, steht diese Expansion im Einklang mit globalen Energietrends und nutzt eine kommerziell skalierbare Technologieplattform. Dieser Schritt erfolgt vor dem Hintergrund einer zunehmenden M&A-Aktivität im Solarsektor und wachsender staatlicher Unterstützung durch Steueranreize und Initiativen für intelligente Netzwerkinfrastrukturen.
- Strategic diversification into high-growth Smart Energy Management sector
- Acquisition of revenue-generating AI software platform
- Entry into recurring revenue business model
- Positioning in market supported by government incentives and strong M&A activity
- Significant departure from core pharmaceutical business
- Risk of integration challenges in new technology sector
- Competition in crowded solar optimization market
Insights
PainReform's strategic expansion into Smart Energy Management (SEM) represents a dramatic business model transformation that deserves careful investor scrutiny. This micro-cap pharmaceutical company (
The move signals two significant developments: First, it establishes a potentially recurring revenue stream through the MyDeepSolar application that could provide more predictable cash flow than the binary outcomes typical in pharmaceutical development. Second, it indicates a substantial strategic pivot that may reflect challenges in the company's original pharmaceutical pipeline.
While the renewable energy sector offers compelling growth opportunities backed by favorable regulatory incentives, this dramatic shift introduces substantial execution risk. PainReform must now simultaneously manage two fundamentally different business lines with distinct expertise requirements, regulatory frameworks, and customer bases.
Most concerning is the complete absence of financial details regarding the acquisition. Without knowing the purchase price, DeepSolar's revenue, or how PainReform funded this acquisition, investors cannot properly assess the immediate financial impact or dilution effects.
For such a small-cap company, this level of business diversification is unusual and suggests either an opportunistic strategy to capitalize on renewable energy trends or potentially a defensive pivot away from pharmaceutical development challenges. The market should closely monitor upcoming financial disclosures to better understand the relative allocation of resources between these disparate business segments.
TEL AVIV, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), a clinical-stage specialty pharmaceutical company and developer of AI-powered energy optimization technologies, today announced its official expansion into the rapidly growing Smart Energy Management (SEM) sector. This move follows the successful acquisition of DeepSolar, a cutting-edge provider of AI-driven software solutions designed to optimize solar energy usage in residential and utility-scale solar power plants.
This strategic expansion marks an important milestone in PainReform’s long-term diversification strategy, aimed at tapping into high-growth, tech-enabled markets. With global solar capacity accelerating amid increasing demand for decentralized, sustainable energy solutions, the ability to measure, analyze, and improve solar energy yield is more critical than ever. Optimization software has emerged as a foundational tool in this transition—driving both economic and environmental value for consumers and enterprises alike.
DeepSolar’s product, MyDeepSolar, is an application that leverages machine learning and predictive analytics to provide real-time monitoring, yield forecasting, and performance optimization for solar-enabled homes.
The app helps maximize the return on solar investments and optimize energy efficiency, by providing homeowners with comprehensive insights into their solar system's performance. It also provides full visibility of the system's status and losses, allowing users to compare actual energy production with the system's potential.
“Our expansion into Smart Energy Management not only aligns with global energy trends but also capitalizes on a technology platform with enormous commercial scalability,” said Ehud Geller, Chairman and interim CEO of PainReform. “We believe DeepSolar has the potential to play a transformative role in a market where intelligent optimization is the key to unlocking the full value of solar energy. The future of energy is decentralized, intelligent, and consumer-empowered—and we intend to be at the forefront of that evolution.”
PainReform’s entry into the SEM market comes amid a flurry of M&A activity and institutional investments in solar and smart energy technologies. Governments worldwide are also ramping up support for residential optimization through tax credits, net metering incentives, and smart grid infrastructure.
By entering a sector with strong macro tailwinds, PainReform is expanding its innovation footprint beyond its pharmaceutical roots, leveraging its AI expertise to address new verticals where data-centric platforms drive recurring revenue and operational scalability.
About PainReform
PainReform Ltd. (Nasdaq: PRFX) is a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, and a developer of AI-driven energy optimization technologies through its DeepSolar platform. The Company’s pharmaceutical programs leverage a proprietary extended-release drug-delivery system intended to provide prolonged post-surgical pain relief while minimizing the need for repeated dosing and reducing reliance on opioids. Through DeepSolar, PainReform also delivers advanced software solutions that enable both consumers and enterprises to monitor, forecast, and optimize energy consumption—particularly in solar-integrated environments. This dual business model reflects PainReform’s strategic commitment to applying precision technology across high-impact sectors including healthcare and sustainable energy. For more information, please visit www.painreform.com.
Notice Regarding Forward-Looking Statements
This press release contains forward-looking statements about PainReform’s expectations, beliefs and intentions including with respect to the anticipated benefits to PainReform of the acquisition of DeepSolar, the anticipated market opportunity and potential for revenue growth. Forward-looking statements can be identified by the use of forward-looking words such as "believe", "expect", "intend", "plan", "may", "should", "could", "might", "seek", "target", "will", "project", "forecast", "continue" or "anticipate" or their negatives or variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical matters. These forward-looking statements are based on assumptions and assessments made in light of management's experience and perception of historical trends, current conditions, expected future developments and other factors believed to be appropriate. Forward-looking statements in this press release are made as of the date of this press release, and we undertake no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, many of which are outside of our control. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward- looking statements, including, but not limited to, the following: our ability to continue as a going concern, our history of significant losses, our need to raise additional capital and our ability to obtain additional capital on acceptable terms, or at all; our dependence on the success of our initial product candidate, PRF-110 and the commercialization of the DeepSolar solution; the outcomes of preclinical studies, clinical trials and other research regarding PRF-110 and future product candidates; our limited experience managing clinical trials; our ability to retain key personnel and recruit additional employees; our reliance on third parties for the conduct of clinical trials, product manufacturing and development; the impact of competition and new technologies; our ability to comply with regulatory requirements relating to the development and marketing of our product candidates; our ability to establish and maintain strategic partnerships and other corporate collaborations; the implementation of our business model and strategic plans for our business and product candidates; the scope of protection we are able to establish and maintain for intellectual property rights and our ability to operate our business without infringing the intellectual property rights of others; the overall global economic environment; our ability to develop an active trading market for our ordinary shares and whether the market price of our ordinary shares is volatile; our ability to maintain our listing on the Nasdaq Capital Market; and statements as to the impact of the political and security situation in Israel on our business, including due to the current war in Israel. More detailed information about the risks and uncertainties affecting us is contained under the heading "Risk Factors" included in the Company's most recent Annual Report on Form 20-F and in other filings that we have made and may make with the Securities and Exchange Commission in the future.
Contact:
Crescendo Communications, LLC
Tel: 212-671-1021
Email: prfx@crescendo-ir.com
Dr. Ehud Geller
Chairman and interim Chief Executive Officer
PainReform Ltd.
Tel: +972-54-4236711
Email: egeller@medicavp.com
